Accuray Inc ARAY
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2007-02-08 |
| Shares Out. | 119,430,000 |
| Website | accuray.com/ ↗ |
| Phone | 16088242800 |
| Employees | 990 |
| Revenue | $104.8M |
| Gross Profit | $25.3M |
| Net Income | -$11.8M |
| Free Cash Flow | -$25.8M |
| Total Assets | $447.6M |
| Total Liabilities | $405.9M |
| Equity | $41.7M |
About Accuray Inc
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
Accuray Inc is a publicly traded company under the ticker symbol ARAY on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-07-01)